Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
Location
601 Brickell Key Drive, Suite 1000, Miami, FL
Fiscal year end
December 31
Former names
Summit Therapeutics plc (to 9/17/2020), Summit Corp plc (to 1/30/2015)
Latest financial report
10-K - Q4 2024 - Feb 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 532 % -0.05%
Debt-to-equity 36.7 % -67.4%
Return On Equity -83.1 % +85.5%
Return On Assets -60.8 % +77.4%
Operating Margin -268K % -6725%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 738M shares +5.09%
Common Stock, Shares, Outstanding 738M shares +5.13%
Entity Public Float 827M USD +663%
Common Stock, Value, Issued 7.38M USD +5.12%
Weighted Average Number of Shares Outstanding, Basic 719M shares +16%
Weighted Average Number of Shares Outstanding, Diluted 719M shares +16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 80.5M USD +94.7%
General and Administrative Expense 60.5M USD +100%
Operating Income (Loss) -226M USD +62.9%
Nonoperating Income (Expense) 13.4M USD +19.5%
Net Income (Loss) Attributable to Parent -221M USD +64%
Earnings Per Share, Basic -0.31 USD/shares +68.7%
Earnings Per Share, Diluted -0.31 USD/shares +68.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 105M USD +46.8%
Cash, Cash Equivalents, and Short-term Investments 186M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 181K USD -62.8%
Assets, Current 424M USD +123%
Property, Plant and Equipment, Net 254K USD +24.5%
Operating Lease, Right-of-Use Asset 7.14M USD +21.9%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 1.86M USD -1.53%
Other Assets, Noncurrent 1.85M USD -57.2%
Assets 436M USD +115%
Accounts Payable, Current 4.64M USD +73.8%
Employee-related Liabilities, Current 12M USD +121%
Accrued Liabilities, Current 19.6M USD +123%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 41.7M USD +105%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 3.45M USD +4.95%
Other Liabilities, Noncurrent 1.63M USD +4.35%
Liabilities 46.8M USD -62.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.29M USD +6.66%
Retained Earnings (Accumulated Deficit) -1.21B USD -22.3%
Stockholders' Equity Attributable to Parent 389M USD +400%
Liabilities and Equity 436M USD +115%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.1M USD -129%
Net Cash Provided by (Used in) Financing Activities 485K USD -99.4%
Net Cash Provided by (Used in) Investing Activities 19.9M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 738M shares +5.13%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.81M USD +98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 105M USD +47.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.5M USD +14.9%
Deferred Tax Assets, Valuation Allowance 95.6M USD +12.8%
Deferred Tax Assets, Gross 95.9M USD +13%
Operating Lease, Liability 7.22M USD +18.3%
Depreciation 27K USD -70%
Payments to Acquire Property, Plant, and Equipment 4K USD -92.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -221M USD +64.1%
Lessee, Operating Lease, Liability, to be Paid 7.98M USD +21.2%
Property, Plant and Equipment, Gross 1.37M USD +10.1%
Operating Lease, Liability, Current 3.77M USD +34%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.81M USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.8M USD +35.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 766K USD +56.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 946K USD +5.94%
Deferred Tax Assets, Operating Loss Carryforwards 59.4M USD +0.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 2.12M USD +99.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.06M USD
Operating Lease, Payments 367K USD +23.6%
Additional Paid in Capital 1.6B USD +49.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 51M USD +261%
Interest Expense 12.6M USD +5378%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%